MedTrace Logo

ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer

NCT05493878 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2022-08-09

No results posted yet for this study

Summary

1. To study the expression pattern of Integrin alpha 2b (ITGA2b) and Selectin P (SELP) genes of Tumor educated platelets in pancreatic and biliary tree cancer and its diagnostic value.
2. To investigate correlation between expression levels of ITGA2b and SELP genes and stages of pancreatic and biliary tree cancer.
3. To investigate correlation between expression levels of ITGA2b, SELP genes, CA 19-9 and CEA in pancreatic and biliary tree cancer patients.

Conditions

  • Pancreas Cancer

Interventions

DIAGNOSTIC_TEST

mRNA expression

Tumor educated platelets ITGA2b and SELP mRNA by reverse transcription-quantitative polymerase chain reaction (RT-qPCR).

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ola A Afifi, doctor · Ola A Afifi

  • Fatma M Helbawi, doctor · Fatma M Helbawi

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-31
Primary Completion
2024-03-31
Completion
2024-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05493878 on ClinicalTrials.gov